HeartBeam to Host Conference Call and Webcast to Discuss Q2 2024 Results
HeartBeam(NASDAQ: BEAT) to discuss second-quarter 2024 results in conference call and webcast. Learn about the company's VECG technology and its potential impact on cardiac care.
This news is important for investors and individuals interested in advancements in medical technology. It provides insight into HeartBeam's progress, as well as its potential impact on the future of cardiac care. The company's focus on personalized insights and portable devices represents a significant shift in the management of cardiac health.